Skip to content
Search

Latest Stories

FIP stresses need for digital health education in pharmacy schools

A majority of the pharmacy schools and faculties around the globe are yet offer digital health education or training, a latest survey by the International Pharmaceutical Federation (FIP) revealed on Wednesday (Jan 27).

The report entitled ‘FIP digital health in pharmacy education: Developing a digitally enabled pharmaceutical workforce’ has surveyed 1,060 pharmacy schools, faculty members, students, and practitioner groups from 91 countries.


It investigated the readiness and responsiveness of pharmacy education with regard to digital health and identified knowledge and skills gaps in the pharmaceutical workforce.

The survey found that many practitioners are lacking familiarity with emerging digital health technologies such as blockchain, bots, digital medicines and artificial intelligence, and only a small fraction of these respondents had received continuous educational development on digital health.

Pharmacy schools and faculties have also reported a lack of experts and resources needed for digital health education.

Professor Aukje Mantel-Teeuwisse, chair of the report group, said: “With increased complexity of health conditions and ageing populations, digital health can be the key to many unmet needs in health services. A capable and digitally enabled pharmaceutical workforce is required to make use of the full potential of digital health."

According to FIP pharmacy education needs to accelerate the uptake of digital health technologies in pharmaceutical care by educating the current and future pharmaceutical workforce.

“Pharmacists historically have embraced information technologies. This report lays the foundation of our current status in pharmacy education for us to build upon. I hope this report and its findings will inspire pharmacy schools to develop and implement lectures or courses in their own curricula, and national and regional professional organisations to equip the pharmaceutical workforce with the necessary digital health knowledge and skills,” Mantel-Teeuwisse added.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less